Tag: Prescription Drugs

Overall, relapse-free survival prolonged among older patients in first remission after chemo who receive CC-486 versus placebo

Changes in doses of antiepileptic drugs occurred more often in pregnant women than in nonpregnant controls

Irinotecan, cetuximab, and vemurafenib improve progression-free survival in BRAF^V600E-mutated colorectal cancer

Enrollment stopped for futility based on no difference in pulmonary function on day 5 compared with placebo

No significant difference seen in mean visual acuity letter score over 24 weeks for patients with proliferative diabetic retinopathy

Current approval of the once-daily tablet indicated for patients who have undergone complete tumor removal

Increased risk for breast cancer observed, which was seen for up to two years after discontinuation of oral contraceptives

Mean number of migraine days per month lower in those receiving rimegepant versus placebo

Cocktail of two antibodies against SARS-CoV-2 spike protein reduces viral load, with greater effect in antibody-negative patients

Increased risks persist beyond six months for patients with lung cancer receiving PD1i and with malignant melanoma receiving CTLA-4i